Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Adma Biologics (ADMA) Inventory Average (2017 - 2025)

Historic Inventory Average for Adma Biologics (ADMA) over the last 12 years, with Q3 2025 value amounting to $194.1 million.

  • Adma Biologics' Inventory Average rose 1038.65% to $194.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $194.1 million, marking a year-over-year increase of 1038.65%. This contributed to the annual value of $171.6 million for FY2024, which is 206.88% up from last year.
  • Adma Biologics' Inventory Average amounted to $194.1 million in Q3 2025, which was up 1038.65% from $181.8 million recorded in Q2 2025.
  • In the past 5 years, Adma Biologics' Inventory Average registered a high of $194.1 million during Q3 2025, and its lowest value of $87.8 million during Q1 2021.
  • Moreover, its 5-year median value for Inventory Average was $163.1 million (2022), whereas its average is $153.1 million.
  • In the last 5 years, Adma Biologics' Inventory Average surged by 8977.42% in 2021 and then crashed by 234.29% in 2025.
  • Over the past 5 years, Adma Biologics' Inventory Average (Quarter) stood at $119.4 million in 2021, then skyrocketed by 36.57% to $163.1 million in 2022, then grew by 3.01% to $168.0 million in 2023, then increased by 1.79% to $171.0 million in 2024, then grew by 13.48% to $194.1 million in 2025.
  • Its Inventory Average was $194.1 million in Q3 2025, compared to $181.8 million in Q2 2025 and $171.2 million in Q1 2025.